BMNDF
Price
$0.31
Change
+$0.07 (+29.17%)
Updated
Nov 19 closing price
CYDY
Price
$0.13
Change
-$0.01 (-7.14%)
Updated
Dec 17 closing price
42 days until earnings call
Ad is loading...

BMNDF vs CYDY

Header iconBMNDF vs CYDY Comparison
Open Charts BMNDF vs CYDYBanner chart's image
BIOMIND LABS
Price$0.31
Change+$0.07 (+29.17%)
Volume$7K
CapitalizationN/A
CytoDyn
Price$0.13
Change-$0.01 (-7.14%)
Volume$1.94M
CapitalizationN/A
BMNDF vs CYDY Comparison Chart
Loading...
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BMNDF vs. CYDY commentary
Dec 19, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BMNDF is a Buy and CYDY is a Buy.

COMPARISON
Comparison
Dec 19, 2024
Stock price -- (BMNDF: $0.31 vs. CYDY: $0.13)
Brand notoriety: BMNDF and CYDY are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BMNDF: 159% vs. CYDY: 75%
Market capitalization -- BMNDF: $24.51M vs. CYDY: $163.46M
BMNDF [@Biotechnology] is valued at $24.51M. CYDY’s [@Biotechnology] market capitalization is $163.46M. The market cap for tickers in the [@Biotechnology] industry ranges from $486.73B to $0. The average market capitalization across the [@Biotechnology] industry is $2.67B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BMNDF’s FA Score shows that 0 FA rating(s) are green whileCYDY’s FA Score has 1 green FA rating(s).

  • BMNDF’s FA Score: 0 green, 5 red.
  • CYDY’s FA Score: 1 green, 4 red.
According to our system of comparison, CYDY is a better buy in the long-term than BMNDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BMNDF’s TA Score shows that 6 TA indicator(s) are bullish while CYDY’s TA Score has 5 bullish TA indicator(s).

  • BMNDF’s TA Score: 6 bullish, 2 bearish.
  • CYDY’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, BMNDF is a better buy in the short-term than CYDY.

Price Growth

BMNDF (@Biotechnology) experienced а 0.00% price change this week, while CYDY (@Biotechnology) price change was -0.45% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -6.67%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +0.65%.

Reported Earning Dates

CYDY is expected to report earnings on Jan 29, 2025.

Industries' Descriptions

@Biotechnology (-6.67% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CYDY($148M) has a higher market cap than BMNDF($25.3M). BMNDF YTD gains are higher at: 207.600 vs. CYDY (-31.282). BMNDF has higher annual earnings (EBITDA): -464.87K vs. CYDY (-13.59M). CYDY has more cash in the bank: 24.9M vs. BMNDF (33.2K). BMNDF has less debt than CYDY: BMNDF (1.03M) vs CYDY (29.2M). BMNDF (0) and CYDY (0) have equivalent revenues.
BMNDFCYDYBMNDF / CYDY
Capitalization25.3M148M17%
EBITDA-464.87K-13.59M3%
Gain YTD207.600-31.282-664%
P/E RatioN/AN/A-
Revenue00-
Total Cash33.2K24.9M0%
Total Debt1.03M29.2M4%
FUNDAMENTALS RATINGS
BMNDF vs CYDY: Fundamental Ratings
BMNDF
CYDY
OUTLOOK RATING
1..100
447
VALUATION
overvalued / fair valued / undervalued
1..100
96
Overvalued
3
Undervalued
PROFIT vs RISK RATING
1..100
83100
SMR RATING
1..100
100100
PRICE GROWTH RATING
1..100
3561
P/E GROWTH RATING
1..100
100100
SEASONALITY SCORE
1..100
n/a22

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

CYDY's Valuation (3) in the null industry is significantly better than the same rating for BMNDF (96). This means that CYDY’s stock grew significantly faster than BMNDF’s over the last 12 months.

BMNDF's Profit vs Risk Rating (83) in the null industry is in the same range as CYDY (100). This means that BMNDF’s stock grew similarly to CYDY’s over the last 12 months.

BMNDF's SMR Rating (100) in the null industry is in the same range as CYDY (100). This means that BMNDF’s stock grew similarly to CYDY’s over the last 12 months.

BMNDF's Price Growth Rating (35) in the null industry is in the same range as CYDY (61). This means that BMNDF’s stock grew similarly to CYDY’s over the last 12 months.

BMNDF's P/E Growth Rating (100) in the null industry is in the same range as CYDY (100). This means that BMNDF’s stock grew similarly to CYDY’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
BMNDFCYDY
RSI
ODDS (%)
Bullish Trend 2 days ago
44%
Bullish Trend 2 days ago
86%
Stochastic
ODDS (%)
Bearish Trend 2 days ago
64%
Bearish Trend 2 days ago
90%
Momentum
ODDS (%)
Bullish Trend 2 days ago
45%
Bullish Trend 2 days ago
87%
MACD
ODDS (%)
Bullish Trend 2 days ago
57%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
41%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
42%
Bullish Trend 2 days ago
81%
Advances
ODDS (%)
N/A
Bullish Trend 6 days ago
85%
Declines
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 6 days ago
50%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
15%
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
BMNDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CYDY
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
DHT9.000.06
+0.67%
DHT Holdings
LFVN16.600.11
+0.67%
Lifevantage Corp
TM173.28-0.97
-0.56%
Toyota Motor Corp
SOFI16.66-0.22
-1.30%
SoFi Technologies
RNAC18.31-0.51
-2.71%
Cartesian Therapeutics

BMNDF and

Correlation & Price change

A.I.dvisor tells us that BMNDF and APM have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that BMNDF and APM's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMNDF
1D Price
Change %
BMNDF100%
N/A
APM - BMNDF
27%
Poorly correlated
+6.57%
LVTX - BMNDF
23%
Poorly correlated
+1.96%
PHGE - BMNDF
22%
Poorly correlated
-1.79%
NKGN - BMNDF
20%
Poorly correlated
+0.07%
CYDY - BMNDF
12%
Poorly correlated
-1.62%
More

CYDY and

Correlation & Price change

A.I.dvisor tells us that CYDY and LVTX have been poorly correlated (+32% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CYDY and LVTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CYDY
1D Price
Change %
CYDY100%
-1.62%
LVTX - CYDY
32%
Poorly correlated
+1.96%
AGNPF - CYDY
24%
Poorly correlated
-20.39%
HUMA - CYDY
21%
Poorly correlated
-12.56%
GNMSF - CYDY
14%
Poorly correlated
-3.12%
BMNDF - CYDY
12%
Poorly correlated
N/A
More